Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers | Zendy

Marc Weiner | Zendy; Eric F. Egelund | Zendy; Melissa Engle | Zendy; Melanie N. Kiser | Zendy; Thomas J. Prihoda | Zendy; Jon Gelfond | Zendy; William Mac Kenzie | Zendy; Charles A. Peloquin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers

Author(s) -

Marc Weiner,

Eric F. Egelund,

Melissa Engle,

Melanie N. Kiser,

Thomas J. Prihoda,

Jon Gelfond,

William Mac Kenzie,

Charles A. Peloquin

Publication year - 2013

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt483

Subject(s) - raltegravir , rifapentine , pharmacokinetics , pharmacology , medicine , posaconazole , tuberculosis , latent tuberculosis , human immunodeficiency virus (hiv) , antifungal , mycobacterium tuberculosis , virology , itraconazole , viral load , antiretroviral therapy , pathology , dermatology

Latent tuberculosis infection and tuberculosis disease are prevalent worldwide. However, antimycobacterial rifamycins have drug interactions with many antiretroviral drugs. We evaluated the effect of rifapentine on the pharmacokinetic properties of raltegravir.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research